Thorax Center, Erasmus Medical Center, Rotterdam, the Netherlands.
Circ Cardiovasc Interv. 2019 May;12(5):e007428. doi: 10.1161/CIRCINTERVENTIONS.118.007428.
Fractional flow reserve (FFR) is the current gold standard to determine hemodynamic severity of angiographically intermediate coronary lesions. Much less is known about the prognostic effects of FFR measured directly after percutaneous coronary intervention (PCI). The aims of this study were to evaluate post-PCI FFR values, identify predictors for a low post-PCI FFR, and to investigate whether a relationship between postprocedural FFR and outcome during 30-day follow-up exists.
The FFR-SEARCH (Fractional Flow Reserve-Stent Evaluated at Rotterdam Cardiology Hospital) is a prospective registry in which FFR measurements were performed after PCI in 1000 consecutive patients. All FFR measurements were performed under maximum hyperemia with intravenous adenosine with the Navvus RXi system (ACIST Medical Systems, Eden Prairie, MN). The clinical end point was defined as a composite of death, target vessel revascularization, or nonfatal myocardial infarction at 30-day follow-up. Measurement of post-PCI FFR was successful in 959 patients (96%), and a total of 1165 lesions were assessed. There were no complications related to the microcatheter. A total of 322 ST-segment-elevation myocardial infarction patients with 371 measured lesions were excluded leaving 637 patients with 794 measured lesions for the final analysis. Overall post-PCI FFR was 0.90±0.07. In 396 lesions (50%), post-PCI FFR was >0.90. A total of 357 patients (56%) had ≥1 lesion(s) with a post-PCI FFR ≤0.90, and 73 patients (11%) had ≥1 lesion(s) with a post-PCI FFR ≤0.80 with post-PCI FFR ≤0.80 in 78 lesions (9.8%). Complex lesion characteristics, use of multiple stents and smaller reference vessel diameter was associated with post-PCI FFR ≤0.90. During follow-up, 11 patients (1.8%) reached the clinical end point. There was no significant relationship between post-PCI FFR and the clinical end point at 30-day follow-up ( P=0.636).
Routine measurement of post-PCI FFR using a monorail microcatheter is safe and feasible. Several lesion and patient characteristics were associated with a low post-PCI FFR. Post-PCI FFR did not correlate with clinical events at 30 days.
血流储备分数(FFR)是目前确定血管造影中度狭窄冠状动脉血流动力学严重程度的金标准。在经皮冠状动脉介入治疗(PCI)后直接测量的 FFR 的预后效果知之甚少。本研究的目的是评估 PCI 后 FFR 值,确定低 PCI 后 FFR 的预测因素,并探讨术后 FFR 与 30 天随访期间结果之间是否存在关系。
FFR-SEARCH(FFR- 在鹿特丹心脏病学医院评估的支架)是一项前瞻性登记研究,其中在 1000 例连续患者中在 PCI 后进行 FFR 测量。所有 FFR 测量均在静脉注射腺苷下使用 Navvus RXi 系统(ACIST Medical Systems,Eden Prairie,MN)进行最大充血。临床终点定义为 30 天随访时死亡、靶血管血运重建或非致命性心肌梗死的复合终点。在 959 例患者(96%)中成功测量了 PCI 后的 FFR,共评估了 1165 处病变。与微导管无关的并发症。排除 322 例 ST 段抬高型心肌梗死患者的 371 处病变后,最终对 637 例患者的 794 处病变进行了分析。整体 PCI 后 FFR 为 0.90±0.07。在 396 处病变(50%)中,PCI 后 FFR >0.90。357 例患者(56%)有≥1 处 FFR <0.90,73 例患者(11%)有≥1 处 FFR <0.80,其中 78 处病变(9.8%)的 FFR <0.80。复杂病变特征、使用多个支架和较小的参考血管直径与 FFR <0.90 相关。在随访期间,11 名患者(1.8%)达到临床终点。PCI 后 FFR 与 30 天随访时的临床终点无显著相关性(P=0.636)。
使用单轨微导管常规测量 PCI 后 FFR 是安全可行的。一些病变和患者特征与低 PCI 后 FFR 相关。PCI 后 FFR 与 30 天的临床事件无相关性。